# Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy

> **NCT00980954** · PHASE3 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 236 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** cisplatin
- **DRUG:** paclitaxel
- **RADIATION:** intensity-modulated radiation therapy
- **RADIATION:** standard external beam radiation therapy
- **RADIATION:** Optional brachytherapy boost

## Key facts

- **NCT ID:** NCT00980954
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2023-12-14
- **Final completion:** 2025-09-04
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2025-12-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00980954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00980954, "Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00980954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*